Press Releases
Upcoming Events
Dec 11, 2022
at 6:00 PM - 8:00 PM CST
An abstract (Abstract# 3334) titled, "A Phase1/1b Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients with Advanced Hematologic and Solid Tumor Malignancies," will be presented as a trial-in-progress presentation.
Dec 12, 2022
at 6:00 PM - 8:00 PM CST
An abstract (Abstract# 4633) titled, "Phase 1/1b Safety Study of PRGN-3006 UltraCAR-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes," will be presented as a poster presentation.
Media Kit
Precigen maintains a media kit with our corporate logo and our CEO’s headshot and bio that can be used by media for editorial purposes. Should you have any questions or seek assets not included in our media kit, please contact:
Download
Media Kit
Media Kit